Scandinavian ChemoTech publishes executive summary of information memorandum
Scandinavian ChemoTech has published an executive summary in English of the information memorandum relating to the ongoing rights issue that was published in Swedish on October 19, 2023.The Board of Scandinavian ChemoTech AB (publ) (”ChemoTech” or the ”Company”) has, with authorisation from the Annual General Meeting on May 16th, 2023, decided on a Rights issue of B-shares for approximately SEK 14.85 million before deduction of issue costs (“The rights issue”). The subscription price has been set to SEK 2.50 per B-share. Those who are shareholders in ChemoTech on the recorded date of